Raissa Alves da Conceição

Dr. Raissa Alves da Conceição

orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 June 2018 in MedChemComm
Verified
Journal Article
Closed access
PDF file
PSPaula Nogueira da Silva
Paula Nogueira da Silva
RCRaissa Alves da Conceição
Raissa Alves da Conceição
RMRodolfo Do Couto Maia
Rodolfo Do Couto Maia
Maria Letícia de Castro BarbosaMaria Letícia de Castro Barbosa
Maria Letícia de Castro Barbosa
Novel SGLT-2 selective inhibitors, an innovative therapeutic approach for glycemia control in diabetic patients.

1 January 2022 in Anais da Academia Brasileira de Ciências
Verified
Journal Article
Open access
JJJéssica B. DE Jesus
Jéssica B. DE Jesus
RCRaissa Alves da Conceição
Raissa Alves da Conceição
TMThayná R. Machado
Thayná R. Machado
Maria Letícia de Castro BarbosaMaria Letícia de Castro Barbosa
Maria Letícia de Castro Barbosa
TDThaisa F.S. Domingos
Thaisa F.S. Domingos
ASAlessandra Souza
Alessandra Souza

5 October 2023 in Journal of Cellular Biochemistry
Verified
Journal Article
Closed access
RCRaissa Alves da Conceição
Raissa Alves da Conceição
NRNatalia von Ranke
Natalia von Ranke
LALuciana Azevedo
Luciana Azevedo
DFDaiana Franco
Daiana Franco
NNNathalia Fonseca Nadur
Nathalia Fonseca Nadur
ASAlessandra Souza
Alessandra Souza

6 June 2025 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
FSFlora Fernanda Schulze Spíndola
Flora Fernanda Schulze Spíndola
APAnderson S. Pinheiro
Anderson S. Pinheiro
MMMaria Athana Mpalantinos
Maria Athana Mpalantinos
JSJefferson R. A. Silva
Jefferson R. A. Silva
WNWalter Sotto Mayor Fernandes Neto
Walter Sotto Mayor Fernandes Neto
IRIgor Almeida Rodrigues
Igor Almeida Rodrigues
Background/Objectives: The anti-Leishmania potential of Curcuma longa and its derivatives, such as curcuminoids, is well-established, yet their mechanisms of action remain underexplored. This study investigates the inhibitory effects of C. longa extracts and curcumin on Leishmania infantum arginase, a key enzyme in polyamine and trypanothione biosynthesis, and evaluates their antiparasitic activity. Methods: Extracts were prepared via rhizome successive maceration with hexane (HEXCURC), dichloromethane (DCCURC), and ethanol (ETOHCURC) and chemically characterized by a combination of chromatographic and spectrometric methods. The inhibition of recombinant L. infantum arginase (LiARG) was assessed by urea quantification, while molecular docking explored interactions between the main compounds annotated in the extracts and the enzyme’s active site. Biological activity was tested against L. infantum promastigotes, intracellular amastigotes, and mammalian cells. Results: LC-MS and GC-MS revealed curcuminoids and turmerones as main compounds annotated in the extracts. DCCURC, HEXCURC, and curcumin showed the strongest LiARG inhibition (IC50 = 10.04, 14.4, and 17.55 μg/mL, respectively). Docking analysis revealed that curcumin, demethoxycurcumin, and bisdemethoxycurcumin bind near the active site, with binding energies of –3.43, –4.14, and –3.99 kcal/mol, respectively. Curcumin demonstrated superior anti-promastigote activity (IC50 = 15.01 μg/mL) and selectivity (SI = 12.7) compared to the extracts. It also significantly reduced amastigote burden in infected macrophages (IC50 = 13.6 μg/mL). Conclusions: This is the first report demonstrating that C. longa extracts and curcumin inhibit LiARG. These findings support curcumin’s potential as a lead compound for developing multi-target therapies against leishmaniasis, combining enzyme inhibition with direct antiparasitic effects.

20 December 2024 in Molecules
Verified
Journal Article
Open access
PDF file
Maria Letícia de Castro BarbosaMaria Letícia de Castro Barbosa
Maria Letícia de Castro Barbosa
PPPedro de Sena Murteira Pinheiro
Pedro de Sena Murteira Pinheiro
RCRaissa Alves da Conceição
Raissa Alves da Conceição
JPJosé Ricardo Pires
José Ricardo Pires
Lucas Silva FrancoLucas Silva Franco
Lucas Silva Franco
Lidia Moreira LimaLidia Moreira Lima
Lidia Moreira Lima
The 4-aminoquinazoline scaffold is a privileged structure in medicinal chemistry. Regioselective nucleophilic aromatic substitution (SNAr) for replacing the chlorine atom at the 4-position of 2,4-dichloroquinazoline precursors is well documented in the scientific literature and has proven useful in synthesizing 2-chloro-4-aminoquinazolines and/or 2,4-diaminoquinazolines for various therapeutic applications. While numerous reports describe reaction conditions involving different nucleophiles, solvents, temperatures, and reaction times, discussions on the regioselectivity of the SNAr step remain scarce. In this study, we combined DFT calculations with 2D-NMR analysis to characterize the structure and understand the electronic factors underlying the regioselective SNAr of 2,4-dichloroquinazolines for the synthesis of bioactive 4-aminoquinazolines. DFT calculations revealed that the carbon atom at the 4-position of 2,4-dichloroquinazoline has a higher LUMO coefficient, making it more susceptible to nucleophilic attack. This observation aligns with the calculated lower activation energy for nucleophilic attack at this position, supporting the regioselectivity of the reaction. To provide guidance for the structural confirmation of 4-amino-substituted product formation when multiple regioisomers are possible, we employed 2D-NMR methods to verify the 4-position substitution pattern in synthesized bioactive 2-chloro-4-aminoquinazolines. These findings are valuable for future research, as many synthetic reports assume regioselective outcomes without sufficient experimental verification.

3 December 2025 in ACS Omega
Verified
Journal Article
Open access
IGIris Paula Guimarães-Andrade
Iris Paula Guimarães-Andrade
RBRodolfo Santos Barboza
Rodolfo Santos Barboza
MSMariana Oliveira Lopes da Silva
Mariana Oliveira Lopes da Silva
RCRaissa Alves da Conceição
Raissa Alves da Conceição
NANathalia Carraio de Albuquerque
Nathalia Carraio de Albuquerque
IMIranaia Assunção Miranda
Iranaia Assunção Miranda
The high frequency of outbreaks, territorial expansion, and cocirculation of different arboviruses reinforce the necessity of efforts for the development of prevention and therapeutic strategies. We previously characterized an anti-Dengue virus activity of 2S-5-hydroxy-4′-methoxy-flavanone-7-O-β-D-apiofuranosyl-(1→6)-β-d-glucopyranoside, a bioactive flavanone glycoside (FvGly) that could be isolated from leaves of different Faramea species. Here, we investigated the ability of FvGly to inhibit other arboviruses, testing against Zika virus (ZIKV), Mayaro virus (MAYV), and Chikungunya virus infections. We demonstrated that FvGly inhibits ZIKV and MAYV infectious particle release from neuronal (SH-SY5Y) and skeletal muscle (C2C12) cells, respectively, when treated before and after viral infection, without presenting a virucidal effect. Treatment with FvGly also results in protection from virus-induced cell death. In agreement, treatment with FvGly reduced the ZIKV and MAYV RNA loads released after infection, and the expression of envelope protein was tightly inhibited in MAYV-infected C2C12 cells. To get insights about the FvGly mechanism, we used target fishing comparative analysis that predicted iNOS, Akt1, and Mapk14 as targets. Molecular docking also supported the high-affinity binding of FvGly with selected targets, mainly iNOS. Finally, we tested the effect of daily treatment with FvGly in a mouse model of MAYV-induced disease. We observed that treatment reduced clinical signs and muscle lesions compared to untreated infected mouse groups. Taken together, our data indicate that, in addition to Dengue, FvGly treatment also has an antiviral and protective effect against ZIKV and MAYV infection.